Find out how NAMs are influencing safety assessments and decision-making in the pharmaceutical industry ahead of 2026.

This biotech has candidates in late-stage clinical development.

To this day, animal testing remains one of the most controversial issues in animal rights. Activists have been fighting ...

Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, a Nelson Labs company, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, discuss how involving procurement ...

HANGZHOU CITY, ZHEJIANG PROVINCE, CHINA, January 20, 2026 /EINPresswire.com/ -- The global fine chemicals industry is ...

The funding will focus on three key areas: fundamental AI, applied AI and talent development. Read more at straitstimes.com.

New “AI GYM for Science” dramatically boosts the biological and chemical intelligence of any causal or frontier LLM, ...

New 'AI GYM for Science' dramatically boosts the biological and chemical intelligence of any causal or frontier LLMUp to 10x performance gains on key drug discovery benchmarks compared to LLMs that ...

The Clinton-Lycoming Joinder Board approved an amendment to a re-investment agreement with PCS-Mental Health which is Project Transitions which will increase to $600,000 the amount for the development ...

Dermatology in the near future will be characterized by digitally enabled, patient-centred research that reaches people where ...

The strongest robotics growth is expected to be in manufacturing, logistics and warehousing, retail and hospitality, ...